Expression of TRAIL, DR4, and DR5 in kidney and serum from patients receiving renal transplantation

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1340-1343

  Song, C J ^a   Liu, X S ^a   Zhu, Y ^a   Chen, L H ^a   Jia, W ^a   Li, Y N ^a   Cao, Y X ^a   Xie, X ^a   Zhuang, R ^a   Zhu, C S ^a   Jin, B Q ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-DR4 ANTIGEN; HLA-DR5 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; REFERENCE VALUES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142540709     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.005     Document Type: Article

References (19)

1. Wiley S.R., Schooley K., Smolak P.J., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673
2. Pitti R.M., Marsters S.A., Ruppert S., et al. Induction of apoptosis by apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem. 271:1996;12687
3. Pan G., Rourke K.O., Chinnaiyan A.M., et al. The receptor for the cytotoxic ligand TRAIL[J]. Science. 276:1997;111
4. Walczak H., Degli-Esposti M.A., Johnson R.S., et al. TRAIL-R2 a novel apoptosis-mediating receptor for TRAIL[J]. EMBO J. 16:1997;5386
5. Degli-Esposti M.A., Smolak P.J., Walczak H., et al. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med. 186:1997;1165
6. Degli-Esposti M.A., Dougall W.C., Smolak P.J., et al. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain[J]. Immunity. 7:1997;813
7. Sheridan J.P., Marsters S.A., Pitti P.M., et al. Control of TRAIL-induced apoptosis by s family of signaling and decoy receptors. Science. 277:1997;818
8. Emery J.G., McDonnell P., Burke M.B., et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL[J]. J Biol Chem. 273:1998;14363
9. Netto M.V., Fonseca B.A., Dantas M., et al. FAS-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation comparison between blood and renal aspirates[J]. Transplant Proc. 34:2002;476
10. Aikawa A., McLaughlin P.J., McDicken I.W., et al. TNF staining of graft biopsies in renal transplantation[J]. Transplantation. 56:1993;231
11. Liu X.S., Zhu Y., Han W.N., et al. Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1 and DcR2[J]. Hybrid Hybridomics. 22:2003;121
12. Simon A.K., Williams O., Mongkolsapaya J., et al. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development sensitivity of human thymocytes[J]. Proc Natl Acad Sci USA. 98:2001;5158
13. Mariani S.M., Krammer P.H. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol. 28:1998;1492
14. Kayagaki N., Yamaguchi N., Nakayama M., et al. Type I interferon (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells A novel mechanism for the antitumor effects of type I IFNs. J Exp Med. 189:1999;1451
15. Walczak H., Miller R.E., Ariail K., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 5:1999;157
16. Sato K., Hida S., Takayanagi H., et al. Antiviral response by natural killer cells through TRAIL gene induction by IFN alpha/beta. Eur J Immunol. 31:2001;3138
17. Song K., Chen Y., Göke R., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med. 191:2000;1095
18. Kischkel F.C., Lawrence D.A., Chuntharapai A., et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptor 4 and 5. Immunity. 12:2000;611
19. Pardo-Mindan F.J., Errasti P., Panizo A., et al. Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil. Nephron. 82:1999;232